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SUMMARY

Esophageal adenocarcinoma (EAC) arises from Barrett esophagus (BE), intestinal-like columnar metaplasia
linked to reflux esophagitis. In a transgenic mouse model of BE, esophageal overexpression of interleukin-1b
phenocopies human pathology with evolution of esophagitis, Barrett-like metaplasia and EAC. Histopathology and gene signatures closely resembled human BE, with upregulation of TFF2, Bmp4, Cdx2, Notch1,
and IL-6. The development of BE and EAC was accelerated by exposure to bile acids and/or nitrosamines,
and inhibited by IL-6 deficiency. Lgr5+ gastric cardia stem cells present in BE were able to lineage trace
the early BE lesion. Our data suggest that BE and EAC arise from gastric progenitors due to a tumorpromoting IL-1b-IL-6 signaling cascade and Dll1-dependent Notch signaling.
INTRODUCTION
Esophageal adenocarcinoma (EAC) has been linked to chronic
inflammation of the esophagus and its incidence has increased
by more than 500% since the 1970s (Corley et al., 2009) despite
powerful acid suppressant medications (proton pump inhibitors)
and a decline in the prevalence of Helicobacter pylori in the
United States and Europe. The main risk factor for EAC is Barrett
esophagus (BE), involving a progression from BE to low-grade/
high-grade dysplasia (Falk, 2002). The precise origin of both

EAC and BE has been difficult to discern in part because of the
absence of useful experimental model systems that are genetically based.
BE has been attributed primarily to gastroesophageal reflux
disease (GERD), leading to chronic inflammation of the esophagus. The link between inflammation and cancer is well established (Grivennikov et al., 2010); in particular, elevated IL-6
has been identified as a key mediator of tumorigenesis in
murine models of cancer (Grivennikov and Karin, 2008). IL-1b,
a pleiotropic pro-inflammatory cytokine upstream of IL-6 and

Significance
Using a transgenic mouse model of BE and EAC, that closely resembles the human disease, insights into the pathogenesis
of BE are provided. A gastric cardia progenitor cell lineage appears to be activated by bile acid-induced and IL-1b- and
IL-6-dependent inflammation, inducing migration into the distal esophagus where it gives rise to columnar-like metaplasia
and dysplasia. Activated Notch signaling appears to regulate differentiation of the cardia progenitor into intestinal-type
columnar cells instead of goblet cells, and is associated with a malignant transformation in mice and humans. Our findings
challenge the common paradigms regarding the pathogenesis of BE and EAC.
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TNF-a signaling cascades, has been demonstrated to induce
tumorigenesis of the mouse stomach (Tu et al., 2008). IL-1b is
overexpressed in BE, and clinical studies have suggested that
polymorphisms in the IL-1b gene cluster are associated with
BE (Fitzgerald et al., 2002; Gough et al., 2005; O’Riordan et al.,
2005).
BE is defined as replacement of the stratified squamous
epithelium in the distal esophagus with a metaplastic, intestinal-like columnar epithelium (Spechler et al., 2010). Whereas
attention in the past has been focused on goblet cells (i.e., classical intestinal metaplasia [IM]) as the primary marker for BE, the
recent change in the definition to include nongoblet, columnar
lined esophagus ([CLE], resembling intestinal and cardia metaplasia) was made to acknowledge the more variable histologic
presentation of BE. A major unanswered question that has
been debated for decades, is whether the BE cell of origin
derives from transdifferentiation of the esophageal squamous
epithelium (Yu et al., 2005), or originates rather from a progenitor
cell in the esophagus (Kalabis et al., 2008), the esophageal
submucosal glands (Leedham et al., 2008), residual embryonic
cells located at the squamocolumnar junction (Wang et al.,
2011), or, as early investigators proposed, the gastric cardia
(Allison and Johnstone, 1953; Barbera and Fitzgerald, 2010;
Hamilton and Yardley, 1977; Nakanishi et al., 2007). However,
prior to the development of IM, a regenerative intestinal-like
columnar cell lineage appears in the esophagus that expresses
TFF2, KRT8, KRT20, NOTCH, and CDX2 (Hanby et al., 1994;
Menke et al., 2010; Stairs et al., 2008; Tatsuta et al., 2005). It is
crucial to identify the progenitors responsible for BE, given the
preneoplastic nature of the lesion.
Until recently, the primary animal model used to study BE
has been a rat model comprising esophagojejunostomy that
induces gastroduodenal reflux (Fein et al., 1998; Li and Martin,
2007). The observation that duodenesophageal reflux induces
EAC in rats points to the importance of refluxed duodenal
contents in the pathogenesis of BE. Bile acids, particularly
unconjugated bile acids such as deoxycholate (DCA) that induce
DNA damage, are one component of gastroduodenal reflux
that have been linked strongly to the development of BE. Reflux
injury in the esophagus results in chronic inflammation with
upregulation of numerous cytokines, such as IL-1b, IL-6, and
IL-8, that might contribute to the metaplastic and dysplastic
conversion of BE (Fitzgerald et al., 2002). Here, we aimed to
utilize a model of Barrett-like metaplasia, involving overexpression of IL-1b, to provide insights into the origins of Barrett
esophagus.
RESULTS
Interleukin-1b Overexpression in the Mouse Esophagus
Induces Esophagitis, Barrett-Like Metaplasia,
and Neoplasia
To understand the pathogenesis of BE and EAC we generated
a model of chronic esophageal inflammation, inserting the
modified human IL-1b cDNA (Björkdahl et al., 1999) downstream
of an Epstein-Barr virus (ED-L2) promoter that targets the oral
cavity, esophagus, and squamous forestomach (Figure S1A
available online) (Nakagawa et al., 1997). In two founder lines
we observed high (Line 1) and low levels (Line 2) of specific

esophageal (and forestomach) hIL-1b mRNA and protein
expression (Figures 1A and 1B) that correlated with upregulated
IL1-receptor-antagonist (IL1ra), indicative of IL-1 receptor
signaling (Figure 1C). No hIL-1b mRNA and protein expression
was observed in the glandular stomach or elsewhere (Figures
1A and 1D). L2-IL-1b mice developed splenomegaly (Figure S1C)
that correlated with age dependent IL-1b expression levels
(Figure 1B), consistent with a systemic inflammatory reaction
and at least 10-fold elevated (p < 0.05) circulating levels of
IL-1b, TNFa (Figure S1D), and IL-6 (Figure 1D).
The esophagus and squamous forestomach in the low and
high expressing L2-IL-1b mice were markedly thickened with
a mixed acute and chronic inflammatory infiltrate compared to
age-matched wild-type (WT) mice (Figure S1B). However, the
major histopathological changes in L2-IL-1b mice occurred at
the squamocolumnar junction (SCJ), an anatomical location
where the squamous and gastric columnar epithelium meet
(Figure 1E) and where the esophagus enters the stomach.
Compared to the human SCJ, the mouse esophagus enters
the stomach at the midpoint of the lesser curvature of the
stomach, at the junction between the glandular stomach and
squamous forestomach, forming a SCJ that traverses the entire
stomach and resembles the Z line in the human esophagus
(Figure S1E). To determine whether the L2-IL-1b mice develop
metaplasia resembling human BE, histological evaluation was
performed on sagittal sections through the esophagus and
stomach (Figure S1E, yellow line). Based upon previously
described criteria (Fox et al., 2000), a histopathological scoring
system for the mouse SCJ was developed. In 100% (10/10) of
the 6-month-old L2-IL-1b mice, we observed moderate inflammation and profound epithelial hyperplasia (Figure 1F) that was
never observed in age-matched WT mice. Proliferation was
increased significantly in the esophageal basal compartment
(Figure 2A).
In L2-IL-1b mice that were 12–15 months of age, 90% (9/10)
developed severe columnar metaplasia (Figures 1E and 1F)
with mucus producing (Muc5ac+, PAS+) cells (Figure 2A) at the
SCJ, similar to human BE. Although classical goblet cells were
not observed in L2-IL-1b mice, the mucus producing columnar
cell types observed were consistent with Barrett-like metaplasia.
Tff2, a marker for metaplasia in human BE (Van De Bovenkamp
et al., 2003; Warson et al., 2002), and also an oxyntic progenitor
cell marker in the gastric corpus (Quante et al., 2010), was not
expressed in the WT esophagus but was upregulated above
the SCJ of L2-IL-1b mice harboring metaplasia but not in
dysplasia (Figure 2A). Electron microscopy studies revealed
nearly identical ultrastructural features (columnar cell type,
microvilli, granules, mucins) in human and mouse BE (Figure 2B).
At 20–22 months of age, 20% (2/9) of L2-IL-1b mice developed
high-grade dysplasia (HGD) or intramucosal EAC (Figures 1E–
1G). These lesions were grossly visible within the distal end of
the esophagus (Figure 1G) and were associated with significant
weight loss (28% ± 4%, p < 0.05; data not shown). During this
stepwise progression to cancer, we observed a gradual increase
in aSMA+ stromal myofibroblasts (Figure 2A) and increasing
stroma global hypomethylation (Figure S2) in BE and HGD
compared to WT, consistent with other models of inflammation-induced cancer (Jiang et al., 2008). Although hypomethylation was prominent in the stroma, we could not exclude (and
Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc. 37
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Figure 1. Overexpression of IL-1b-Induced Chronic Inflammation in the Murine Esophagus and Stepwise Development of Metaplasia
and Dysplasia at the SCJ
(A) mRNA expression (RT-qPCR) in different organs of 3-month-old two founder L2-IL-1b-lines.
(B) ELISA for human (transgenic) IL-1b showed age dependent hIL-1b protein expression levels.
(C) mRNA expression (RT-qPCR) of IL1-receptor-antagonist (IL1ra) in different organs in 12-month-old L2-IL-1b mice compared to WT littermates.
(D) ELISA for serum levels and organ protein expression of mIL-6 in L2-IL-1b mice compared to WT (C57/B6) littermates.
(E) Histopathologic changes in L2-IL-1b mice occurred at the squamo-columnar junction (SCJ, arrow in WT). Representative pictures of WT and 6-, 9-, 12-, 15-,
and 20-month-old L2-IL-1b, top panels show an overview of the SCJ, where the squamous esophagus epithelium meets the columnar cardia/stomach
epithelium, second and third panels show inset magnifications of the stepwise progression to BE and EAC.
(F) Histopathologic scoring of 6-, 9-, 12-, 15-, and 20-month-old L2-IL-1b mice compared to WT (C57/B6) littermates.
(G) Representative gross pictures of the SCJ in WT and 20 months old L2-IL-1b mice with tumor (arrow). Data are represented as mean ± SEM. *p < 0.05,
**p < 0.01. See also Figure S1.
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Figure 2. IL-1b Mouse Model Resembles the Human Disease
(A) Representative pictures of staining for PAS, Muc5ac, Krt19, Tff2, Ki67, and aSma of normal SCJ histology in WT (left panel), BE histology in 15-month-old
L2-IL-1b mice (middle panel), and HGD histology in 22-month-old L2-IL-1b mice (right panel).
(B) Representative electron microscopy pictures of mouse (top panel) human (bottom panel) BE epithelium showing columnar cells (left), granules with mucin
(middle), and microvilli (right). Scale bar represents 2 mm.
(C) Representative pictures of b-catenin, p16 and c-myc in WT mice and dysplastic tissue of 16-month-old BA-treated L2-IL-1b mice.
(D) Western blot for p53, p-Erk, and p-Akt in indicated tissues, showing p53 stabilization, and activation of Akt and Erk pathways in EAC- and BA-treated BE.
See also Figure S2 and Table S1.

indeed suspect) gene specific hypermethylation in epithelial cells
as described in humans (Sato and Meltzer, 2006).
Within the epithelial compartment, we observed stabilization
of nuclear b-catenin (Figure 2C), a finding suggested by gene
expression microarrays of WT and HGD tissue following
laser capture microdissection (LCM) of metaplastic lesions in
L2-IL-1b mice (Table S1). This microarray analysis confirmed
an upregulation of b-catenin, EVI1, and RRas in the tumors,
consistent with activation of these pathways. Pathway analysis
also revealed markedly increased phosphorylation of Akt and
Erk in HGD samples (Figure 2D), compared to only a slight
increase in BE-like metaplasia, especially after bile acid treatment, and absent expression in WT cardia tissue (Figure 2D).
We also observed occasional loss of p16 and increased c-Myc
expression or stabilization of p53 in the neoplastic epithelium
(Figures 2C and 2D), thus demonstrating involvement in our

mouse model of BE/EAC of a number of pathways relevant to
human BE and EAC.
Bile Acids and Carcinogens Accelerate the
Development of Barrett-Like Metaplasia and Dysplasia
that Can Be Diagnosed Endoscopically in the Mouse
BE and EAC have been attributed to acid reflux leading to
chronic esophagitis. In our mouse model of chronic inflammation, Barrett-like metaplasia and dysplasia appeared to be
more dependent upon IL-1b overexpression than acid exposure,
because both WT mice and L2-IL-1b mice were kept on acidified
water (pH % 2.0) but pathological changes were evident only
in the EL2-IL-1b mice. Unconjugated bile acids are another component of gastroduodenal reflux that has been linked to the
development of BE. Consequently, we treated 2–3-month-old
L2-IL-1b mice (line 2) and WT littermates with an unconjugated
Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc. 39
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Figure 3. Bile Acids and Carcinogens Accelerate the Development of Barrett Metaplasia and Dysplasia
(A) Histopathological scoring of 6-, 9-, 12-, and 15-month-old BA-treated L2-IL-1b mice and combined 12 months old BA and N-methyl-N-nitrosourea
(MNU)-treated L2-IL-1b mice compared to WT (C57/B6) littermates (*p < 0.05 compared to WT, #p < 0.05 compared to untreated L2-IL-1b mice).
(B) Representative gross pictures of the SCJ in WT, 22-month-old L2-IL-1b mice, 15-month-old BA-treated L2-IL-1b mice, and combined BA and MNU-treated
12-month-old L2-IL-1b mice with tumors at the SCJ.
(C) Representative pictures of the esophagus and SCJ during upper endoscopy in intact 15-month-old BA-treated or untreated L2-IL-1b mice and WT mice
and corresponding gross macroscopic evaluation (right).
(D) PET imaging was performed on a rodent microPET scanner to measure glucose uptake in tumors relative to normal tissue. A representative picture of
15-month-old BA-treated L2-IL-1b mice is shown in sagittal, coronal, and axial position (arrow indicates the tumor that was macroscopically and histologically
confirmed). Data are represented as mean ± SEM. See also Movies S1–S5 and Figure S3.

bile acid ([BA], 0.2% deoxycholate) in the drinking water (pH 7)
and analyzed the mice at 6, 9, 12, and 15 months (Figure S3A).
Due to issues of solubility, BA were administered in pH 7.0 water,
thus eliminating the possibility of acid exposure.
Six-month-old BA-treated L2-IL-1b mice showed severe
esophagitis with inflammatory infiltrates, but only moderate
changes were observed in BA-treated WT mice (Figures 3A
and 3B). Sixty percent (6/10) of 9-month-old BA-treated
40 Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc.

L2-IL-1b mice showed metaplastic changes at the SCJ, with
higher overall metaplasia scores compared to untreated L2IL-1b mice (2.7 versus 1.8, p < 0.05) (Figure 3A; Figure S3C),
indicating a significant acceleration by BA of Barrett-like metaplasia. Moreover, we observed more severe metaplasia and
dysplasia in BA-treated L2-IL-1b mice compared to untreated
L2-IL-1b mice at both 12 months (dysplasia score 2.1 versus
1.0, p < 0.05) and 15 months (dysplasia score 2.4 versus 1.4,
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p < 0.01) (Figure 3A; Figure S3C). Forty percent (4/9) of 15month-old BA-treated L2-IL-1b mice presented with macroscopically visible tumors in the distal esophagus (Figure 3B),
and exhibited significant weight loss consistent with partially
obstructive lesions. These data suggest that BA play a significant
role in the pathogenesis of BE and dysplasia, although we did not
use bile acids at pH 2.0 and cannot rule out that gastric acid
might also have a role in esophageal carcinogenesis.
N-nitrosamines are generated typically at the SCJ from reduction of salivary nitrite to nitric oxide in response to gastric juice
(Winter et al., 2007) and might play a role in the pathogenesis
of BE. N-methyl-N-nitrosourea (MNU) is a known gastric
carcinogen for mice (Tomita et al., 2011), but does not appear
to promote transformation of the noninflamed esophageal
epithelium (Figures S3A and S3B). Mucosa that is chronically
inflamed is thought to be more sensitive to the effects of luminal
carcinogens (Winter et al., 2007). Thus, in comparison to
BA+MNU-treated WT mice (Figure S3B), we observed a significant increase in tumor development in 12-month-old
BA+MNU-treated L2-IL-1b mice (Figures 3A and 3B).
Patients with EAC lose weight due to luminal obstruction, typically diagnosed by endoscopy and/or noninvasive imaging.
Upper endoscopy in intact 15-month-old BA-treated or
untreated L2-IL-1b (Movies S1 and S2) and WT (Movie S3)
mice after intubation and under constant ventilation (Figure 3C)
revealed the luminal presence of BE-like metaplasia and tumor
growth in the distal esophagus. The esophagi of L2-IL-1b mice
showed circumferential erythema and edema with inflammatory
exudates compared to the normal esophagus (Figure 3C),
changes that were increased in BA-treated L2-IL-1b mice.
The endoscopic appearance resembled human BE (Movie S4).
In four of nine BA-treated L2-IL-1b mice (15 month) but no
L2-IL-1b mice (15 month), we observed obstructing tumors at
the SCJ (Figure 3C; Movies S1–S3). 18F-FDG PET scans of
BA-treated L2-IL-1b mice with endoscopically detected tumors
revealed markedly increased focal glucose uptake, consistent
with the severe inflammation in the esophagus and forestomach,
along with tumorigenesis confirmed histologically (Figure 3D;
Movie S5). These imaging data provide support for the acceleration of neoplastic processes in L2-IL-1b mice by BA.
Bile Acids Induce an Acute and Chronic Immune
Response and Activate Differential Gene
Expression in BE
Previous studies of IL-1b-induced carcinogenesis suggested
that recruitment of myeloid cells is crucial for the development
of neoplasia (Tu et al., 2008; Yang et al., 2011). In 6-month-old
L2-IL-1b mice with mild esophagitis, there was no change in
the abundance of CD4+ and CD8+ T cells or CD11b+/F4/80+
monocytes/macrophages in esophageal tissue, but a significant
accumulation of immature (CD11b+Gr1+) myeloid cells (Figure 4C). At 9, 12, and 15 months, there was an even greater
accumulation in L2-IL-1b mice of CD11b+Gr1+ cells in the esophagus (Figure 4C) and spleen (not shown) associated with chronic
esophagitis and metaplasia. CD4+ T cells, F4/80+ macrophages
and CD11b Gr1+ neutrophils were also significantly increased
but to a lesser extent in L2-IL-1b mice at these later time points
(Figure 4B). Inflammatory cytokines were increased (Figures 1A–
1D; Figure S1D) and the L2-IL-1b mice developed splenomegaly,

likely due to an accumulation of immature splenic myeloid cells
(Figure S1C). BA treatment resulted in additional increases in
CD4+ T cells and CD11b Gr1+ neutrophils, along with a slight
decrease in CD11b+Gr1+ cells but no changes in CD11b+/F4/
80+ macrophages (Figures 4A and 4B). These observations
confirmed our histopathological scoring, showing more acute
inflammation in BA-treated mice (Figure 3A). Our data suggest
that BA may contribute to the development of BE by shifting
the chronic inflammatory response toward an acute neutrophilic
response. Recruited macrophages also suggest a role for
tumor associated macrophages (TAMs) in BE.
In addition, 15 month BA-treated L2-IL-1b mice harboring
metaplasia showed elevated levels of Tff2, Cckbr, Muc5ac,
Cdx2, and Krt19 (Figure 4D). Bmp4, Cdx2, and Shh, which are
known to be involved in cellular differentiation and proliferation,
were also associated with BA treatment (Figure 4D). Interestingly, we observed a significant upregulation of Notch1 upon
BA treatment, indicating a potentially important role for the
Notch signaling pathway in BE and HGD (Figure 4D).
DLL1-Dependent Notch Signaling Regulates
Differentiation and Correlates with Progression
Notch signaling is an essential factor in intestinal differentiation
and seems to be required to maintain stem cells in an uncommitted state (Kim and Shivdasani, 2011). As with the intestinal
epithelium, the Barrett epithelium contains proliferative cryptlike compartments, and the Notch pathway has been found to
be active in BE (Menke et al., 2010). Indeed, Notch1 was upregulated significantly in the epithelium at the SCJ of BA-treated
L2-IL-1b mice, compared to WT and untreated L2-IL-1b mice
(Figures 4D and 5A; Figure S4A), pointing to a role of Notch
signaling during EAC pathogenesis. Notch inhibition by systemic
treatment with a g-secretase inhibitor (DBZ), as reported
previously (Menke et al., 2010), markedly increased both PAS+
cells and Alcian-Blue(+) goblet-like cells (Figures 5B and 5C),
suggesting that inhibition of Notch signaling is associated with
IM. Moreover, IHC for a general marker of activated Notch
signaling (Notch intracellular domain or NICD; Figure S4A)
revealed that NICD-expressing cells were predominantly found
within columnar-lined esophagus (CLE) and dysplastic epithelial
tissue at the SCJ, but not in IM at the SCJ, and were in general
not present in DBZ-treated mice (Figure 5A; Figure S4A) where
we observed increased numbers of goblet cells (Figure 5C).
These findings suggest that Notch signaling might contribute
to the development of dysplasia, whereas inhibition of Notch
signaling results in goblet cell differentiation and may prevent
malignant transformation, although in theory both processes
could occur simultaneously in different regions of the metaplastic epithelium.
We also observed upregulation of the Notch ligand Delta-like1
(Dll1) in BE-like tissue (Figure 5D; Figures S4C and S4D), which
correlated with increased Notch1 expression and proliferation
in BE. Increasing numbers (Figure S4E) of Dll1-expressing cells
could be found adjacent to Notch activated cells (Notch-IC),
suggesting a possible intraepithelial crosstalk (Figure 5D). Most
of the Dll1+ cells also expressed Tff2, supporting a concept of
an expansion of Dll+ cells in the BE lineage (Figure S4F). In
addition, we found downregulated Jagged2 gene expression in
BE and EAC (Figure 6D; Table S1) and were able to confirm
Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc. 41
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Figure 4. Bile Acids Induce an Acute and Chronic Immune Response and Activate Notch Signaling in BE
(A) The frequencies of lymphoid and myeloid cells in the esophagus from 12-month-old L2-IL-1b mice and age-matched WT mice were measured by FACS,
and representative FACS blots for detecting immature (CD11b+Gr1+) myeloid cells in the esophagus from WT, L2-IL-1b mice, BA-treated WT, and BA-treated
L2-IL-1b mice are shown.
(B) Quantitative analysis of FACS for immature (CD11b+Gr1+) myeloid cells, neutrophiles/granulocytes (CD11b Gr1+), macrophages (Cd11b+/F4/80+), and T cells
(CD4+) (*p < 0.05 compared to WT, #p < 0.05 compared to BA-treated WT, $p < 0.05 compared to untreated L2-IL-1b mice).
(C) Quantitative analysis of FACS for immature (CD11b+Gr1+) myeloid cells in 6-, 9-, 12-, 15-month-old L2-IL-1b mice compared to age-matched WT mice.
(D) mRNA expression (RT-qPCR) of Cdx2, K19, Cckbr, Muc5ac, TFF2, Shh, Bmp4, and Notch1 in the SCJ tissue of WT, L2-IL-1b mice, BA-treated WT, and
BA-treated L2-IL-1b mice (*p < 0.01 compared to WT, # p < 0.05 compared to L2-IL-1b mice). Data are represented as mean ± SEM.

decreased Jagged2 as assessed by IHC (Figure S4B), suggesting that Dll1, not Jagged2, is the predominant ligand inducing
Notch signaling in BE. The location of Dlll1 expression was associated with the normal stem cell zone in the gastric cardia (data
not shown), whereas Jagged2 appeared to be expressed in
more terminally differentiated areas of the gastric cardia glands
(Figure S4B, data not shown).
To confirm these findings from our mouse model, we analyzed
46 human BE biopsy samples. Biopsies were taken from Barrett
mucosa, evaluated by an expert gastrointestinal pathologist, and
samples were classified histologically based on the highest
degree of neoplasia present on any of the biopsies. Notch1
was significantly upregulated in human biopsies of dysplastic
tissues compared to BE tissue (Figure 5E), pointing to a role of
Notch signaling in the development of EAC from BE. Overall,
Notch activation appears to be associated with decreased
goblet cell differentiation, as suggested by a lack of goblet cells
42 Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc.

in adjacent tissue of human EAC samples (unpublished data) and
a review of the literature (Table S2). IHC for Notch intracellular
domain (NICD) and Dll1 in human BE tissue showed a similar
pattern, where expression of the receptor and ligand was found
in adjacent but distinct cell types (Figure 5F).
Gene Expression Profiles of the IL-1b Mouse Esophagus
Closely Resemble Those of Human Barrett Metaplasia
and Esophageal Adenocarcinoma
The gene expression profile of human BE (Stairs et al., 2008) is
only slightly more similar to small intestine than it is to normal
esophagus, in contrast to the striking similarity of BE morphology
to intestinal morphology. Nevertheless, we found in both human
BE and our mouse model that a number of gastric and intestinal
genes were significantly upregulated. LCM was applied to
typical metaplastic lesions in L2-IL-1b mice (with or without
BA), and to the squamous epithelium of WT mice (Figure 6A).
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Figure 5. Notch Signaling in BE
(A) Representative pictures of NotchIC IHC in 15-month-old L2-IL-1b BA-treated mice and 9-month-old L2-IL-1b mice after g-secretase inhibitor treatment (DBZ).
(B) Representative pictures of periodic acid-Schiff (PAS) and Alcian blue staining at the SCJ of 9-month-old L2-IL-1b without and with 10 days g-secretase
inhibitor treatment (right, Notch signaling inhibitor, DBZ).
(C) Representative picture of BE in g-secretase-treated L2-IL-1b mice showing occasional true goblet cells (white arrows), CLE (green arrows), and goblet like
cells (red arrows) on the left. On the right goblet cells in BE (top) and small intestine (SI, bottom) are shown to show similarities in intestinal metaplasia.
(D) Representative pictures of NotchIC (red) and Delta-Like1 (DII1) (green) IHC in 9-month-old WT, 9-month-old L2-IL-1b with BE, and 15-month-old BA-treated
L2-IL-1b with EAC (insets label magnified area below).
(E) mRNA expression (RT-qPCR) of Notch1 in biopsies of esophageal tissue, obtained from 46 patients with BE with and without dysplasia. In each patient,
biopsies were taken from Barrett mucosa and from dysplastic appearing mucosa.
(F) Representative pictures of NotchIC (red) and Delta-Like1 (DII1) (green) IHC in human BE with CLE or IM. See also Figure S4 and Table S2. Data are represented
as mean ± SEM. *p < 0.05.
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Figure 6. Gene Expression Profiles of Mouse BE Resembles that of the Human Disease
(A) Laser capture microdissection (LCM) was applied to typical metaplastic lesions at the SCJ in 15-month-old L2-IL-1b mice or 9-month-old BA-treated L2-IL-1b
mice and to the squamous epithelium of WT control mice. A schematic sequence of the experimental procedures is shown: (A) After LCM (a representative
outlined area is shown) followed by RNA isolation and amplification, (B) Venn diagram mouse BE versus BA-treated mouse BE: gene expression of BE tissue from
untreated L2-IL-1b mice (n = 3, BE versus N), and BA-treated L2-IL-1b mice (n = 3, BeBA versus N) was compared to WT squamous tissue (n = 3) in order to
determine the overlapping up- and downregulated genes in both cohorts.
(C) Venn diagram mouse versus human. These 3,832 significantly different genes (1,676 up [Venn diagram: A] and 2,166 down [Venn diagram: B], p < 0.01) were
than compared to the gene expression pattern of a human expression analysis (Stairs et al., 2008) where human BE tissue was compared to human esophageal
squamous tissue. This comparison identified 606 genes, which were analyzed by KEGG pathway analysis.
(D) A list of these significantly identical genes in human and mouse is shown with the log2 fold change of the comparison of BA-treated L2-IL-1b mice compared to
the squamous epithelium of WT control mice.
(E) KEGG pathway analysis also identified genes that were altered differentially in BE epithelium of L2-IL-1b mice versus BA-treated L2-IL-1b mice (Venn diagram:
C–F). A list of significantly different genes is shown.

Compared to squamous epithelium, we observed 5,698 genes
with a significance cutoff of <0.05, that were differentially
regulated in BE tissue of 15-month-old L2-IL-1b mice and
5,950 genes in 9-month-old BA-treated L2-IL-1b mice. Direct
comparison of these two groups identified 1,678 similarly upregulated (A in Venn diagram) and 2,166 similarly downregulated
(B in Venn diagram) genes (Figure 6B). In KEGG pathway
analysis, these transcripts were enriched for cell adhesion
44 Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc.

molecules, adherens junctions, tight junctions, biosynthesis of
unsaturated fatty acids, PPAR signaling pathway, and protein
export. When compared to the earlier human expression
analysis (GSE13083) (Stairs et al., 2008), entire sets of genes in
the mouse were altered in the same directions (Figure 6C).
KEGG pathway analysis of those genes that were identically
up- or downregulated in mouse and human, revealed changes
in the expression of genes relevant for bile acid-induced
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damage, signaling pathways (i.e., Notch), columnar cell related
genes, and cell-cell contact genes (Figure 6D).
KEGG pathway analysis also identified genes that were
altered differentially in BE-like epithelium of L2-IL-1b mice versus
BA-treated L2-IL-1b mice (C–F in Venn diagram) with a significant
overrepresentation of the biological processes of mismatch
repair, adherens junction, apoptosis, and autophagy, as well
as alterations in signaling pathways with importance for carcinogenesis (Figure 6E). These results are consistent with a role
for bile acids in promoting metaplasia and cancer by loosening
cell-cell contacts, inducing oncogenic pathways, and causing
cell death by DNA damage and oxidative stress.
Barrett-Like Metaplasia and Dysplasia Correlate
with Expansion of Gastric Cardia Progenitor
Cells in Mice and Humans
The current paradigm suggests that BE derives from dedifferentiation or transdifferentiation of the squamous esophageal
epithelium (Jankowski et al., 2000). To address the possible
origins of BE in our mouse model, we examined the expression
and localization of a number of putative stem cell or progenitor
cell markers. Lgr5/GPR49 is a validated stem or progenitor cell
marker for the mouse gut, but in the stomach it is expressed
only in the gastric antrum and in the gastric cardia (Barker
et al., 2010). Krt19 and Tff2 have been shown through lineage
tracing studies to label different gastric progenitor cells
(Means et al., 2008; Quante et al., 2010). Doublecortin and
CaM like-kinase-1 (Dclk1), a microtubule-associated kinase
expressed in neurons, has been postulated to be expressed in
gut epithelial progenitors (Giannakis et al., 2006).
Although the above markers were absent from the normal
squamous esophageal epithelium, they showed increased
expression over time in our L2-IL-1b mouse model, with expression first in the gastric cardia and later above the SCJ. In qRTPCR studies Lgr5 was expressed minimally in the WT cardia,
but could easily be detected in the cardia in 15-month-old
L2-IL-1b mice that showed features consistent with Barrett
metaplasia (Figure 7B). Lgr5-labeled cells were present in the
cardia of Lgr5-Cre-ERT mice crossed to Rosa-LacZ reporter
mice shortly after tamoxifen induction, which within 7 days
gave rise to lineage traced cardia epithelium in WT mice (Figure 7D), as previously shown (Barker et al., 2010). In L2-IL-1b
mice crossed to Lgr5-Cre-ERT/Rosa-LacZ mice, we observed
labeled BE metaplasia four months after tamoxifen induction followed by BA treatment at the age of 6–8 weeks (Figure 7D).
These findings indicate that Lgr5+ cells within the cardia may
function as progenitor cells, and thus potentially as the cells of
origin for BE and dysplasia. Furthermore, we observed an
increase in protein and mRNA expression of the Krt19 gene
(Figures 2A and 4D), which is a known marker for surface mucus
and gastric progenitor cells (Brembeck et al., 2001; Means et al.,
2008), and of the Tff2 gene, expressed in gastric and cardia
mucus neck and progenitor cells (Quante et al., 2010), but not
in the normal esophageal epithelium (Figures 2A and 4D). Finally,
we found an accumulation of Dclk1+ cells adjacent to the
metaplastic mucus producing cells in BE tissue (Figures 7A
and 7B). Dclk1+ cells are typically present as rare scattered cells
localized primarily to the isthmus of the gastric glands (data not
shown), but Dclk1+ cells are highly abundant in the gastric

cardia, particularly just below the SCJ (Figure 7A). The gradual
accumulation of Dclk1+ cells just above the SCJ in L2-IL-1b
mice positively correlated with the development of metaplasia
at the SCJ; with progression to dysplasia, Dclk1 expression
was downregulated.
In human BE, qRT-PCR analysis showed a highly significant
upregulation of LGR5 and DCLK1 compared to normal squamous epithelium (Figure 7C). Moreover, IHC for DCLK1 showed
increased expression in dysplastic BE and decreased (or absent)
expression of DCLK1 in dysplasia or adenocarcinoma (Figure 7A), similar to the observation in L2-IL-1b mice. Consistent
with previous reports, TFF2 was highly expressed in Barrett
mucosa but not in biopsies of squamous esophageal epithelium
(data not shown). Interestingly, LGR5 and DCLK1 were significantly elevated in the gastric cardia of BE patients (Figures 7E
and 7F). The upregulation of gastric columnar progenitor cells
in the region of the cardia and in BE suggest that the metaplastic
lineage in BE lesions in mice and humans may derive from
a gastric cardia lineage (Figure 4G).
IL-6 Deficiency Abolishes Inflammation, Metaplasia,
and HGD in L2-IL-1b Mice
IL-1b is upstream of IL-6 and TNF-a, which are both upregulated in our models (Figure S1D) and overexpression of IL-1b
has been shown to induce tumorigenesis of the stomach (Tu
et al., 2008). Persistent activation of the transcription factor
signal transducer and activator of transcription-3 (Stat3) occurs
in a large number of solid malignancies and supports the proliferation and survival of malignant cells, mostly triggered by an
autocrine-paracrine production of IL-6 and family members
(Bollrath et al., 2009). We observed elevated IL-6 protein levels
in the serum and the SCJ of L2-IL-1b mice (Figure 1D), and IL-6
could be upregulated further by BA treatment (Figure 8A). IHC
revealed increased pStat3+ cells during the progression from
normal esophagus to BE and EAC (Figures 8B and 8C). Interestingly, we observed a significant upregulation of IL-11Ra
and Jak2, and downregulation of Socs3, in our microarray analysis (Table S3). Given that we demonstrated increased levels
of IL-6 and phosphorylated Stat3 in mouse BE-like and
dysplasic tissues, IL-11Ra upregulation likely represents an
inhibitory feedback mechanism. The finding of SOCS3 downregulation, as demonstrated recently (Watanabe et al., 2007), and
increased levels of Jak2 with STAT3 activation, suggest
a mechanism by which IL-1b and IL-6 could induce the development of cancer in our mouse model of BE/EAC (Lesina et al.,
2011).
In human EAC samples qRT-PCR analysis showed a significant
upregulation of IL-6 and IL-1b compared to BE samples (Figures
8D and 8E), supporting our hypothesis that both cytokines play
an important role during EAC pathogenesis. When we crossed
L2-IL-1b mice with IL-6 / mice we observed a complete abolishment of the metaplastic and dysplastic phenotype in homozygous L2-IL-1b/IL-6 / mice, and a partly diminished phenotype
with little metaplasia and no dysplasia in heterozygous L2IL-1b/IL-6 /+ mice (Figure 8F). In L2-IL-1b/IL-6 / mice, we
observed only a minor inflammatory response, which was
increased in L2-IL-1b/IL-6 /+ mice, but no increase in pSTAT3+
cells could be detected (data not shown). These data indicate
that IL-1b mediates its carcinogenic effect in part through IL-6,
Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc. 45
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Figure 7. Barrett Metaplasia and Dysplasia Arise from Gastric Cardia Progenitor Cells in Mice and Humans
(A) Representative pictures of human (left) and mouse (right) SCJ, BE, and EAC tissue with doublecortin like kinase-1 (Dclk1) IHC.
(B) mRNA expression (RT-qPCR) of Lgr5 and Dclk1 in the SCJ tissue of WT, L2-IL-1b mice, BA-treated WT, and BA-treated L2-IL-1b mice.
(C) mRNA expression (RT-qPCR) of Lgr5 and Dclk1 in biopsies of esophageal tissue, obtained from 46 patients with BE. In each patient, biopsies were taken
from Barrett mucosa and from normal-appearing squamous mucosa.
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suggesting the presence of a tumor-promoting IL-1b-IL-6-pStat3
signaling cascade in mouse EAC.
DISCUSSION
Using a transgenic mouse model of esophageal inflammation,
we demonstrate that increased IL-1b expression is sufficient
for the induction of Barrett-like metaplasia and dysplasia at the
SCJ, extending previous findings in the glandular stomach (Tu
et al., 2008) and affirming a crucial role for IL-1b in carcinogenesis, which is highly upregulated in human BE and EAC (Fitzgerald et al., 2002). Gene expression analysis, IHC, EM, and endoscopy provided evidence that our IL-1b mouse model closely
resembles human disease, despite the fact that the mouse
stomach differs from the human stomach. Inflammation in the
squamous esophagus resulted in migration of cardia progenitor
cells (including Lgr5+ cells) and their metaplastic descendants
into the esophagus. We would conclude then that Barrett esophagus is derived from gastric cardia progenitors at the SCJ
junction.
Although our L2-IL-1b mouse model exhibits a columnar-lined
esophagus (CLE) but lacks abundant goblet cells (or classical
IM), it is increasingly recognized that BE does not require classical IM to establish the diagnosis (Ogiya et al., 2008; Playford,
2006). Several studies have indicated that the risk of progression
to EAC is the same in patients with CLE without goblet cells as it
is in patients with IM (Gatenby et al., 2008; Goldblum, 2010; Kelty
et al., 2007; Odze and Maley, 2010; Riddell and Odze, 2009;
Takubo et al., 2009) (Table S2), and our clinical experience would
support this broader premise. The findings that dysplasia tends
to recur following radiofrequency ablation in the presence of CLE
without classical IM would support this model (Vaccaro et al.,
2011). Notch inhibition has been associated with goblet cell
differentiation (Menke et al., 2010), and thus the absence of
Tff3+ or Muc2+ goblet cells may be related to the high levels of
Notch expression. Our study adds to the evidence challenging
the notion that metaplastic nongoblet cell CLE is entirely benign,
and we would even argue that TFF2 has many advantages as
a marker for BE, because it seems to be expressed early in the
development of CLE, a lesion we postulate is the primary
precursor lesion for EAC. Nevertheless, further studies in
patients are needed to clarify the prognostic and diagnostic
value of IM and CLE, because at present it remains controversial
as to which metaplastic epithelial subtype best defines BE
(Chatelain and Fléjou, 2003), leading to controversial risk estimates for the development of HGD or EAC in BE patients
(Hvid-Jensen et al., 2011).
IL-1b overexpression was able to induce metaplasia and
dysplasia of the SCJ in part through recruitment of immature

myeloid cells (IMC), which have been linked to carcinogenesis
(Stairs et al., 2011; Tu et al., 2008; Yang et al., 2011). IMC were
increased early in the distal esophagus and likely contribute to
esophageal inflammation and carcinogenesis through secretion
of pro-inflammatory cytokines (IL-6 and Tnf-a) and chemokines
(Sdf1). With BA treatment, there was acceleration of dysplasia
and a shift in the myeloid phenotype more toward granulocytic
differentiation, pointing to the possible significance of a mixed
acute/chronic inflammatory response in carcinogenesis (Fridlender et al., 2009). IL-6 levels were systemically elevated in
L2-IL-1b mice, and IL-6 deficiency completely abrogated the
IL-1b-induced phenotype, indicating the importance of systemic
immune activation in the development of neoplasia. Persistent
activation of Stat3 through IL-6 additionally supports the proliferation and survival of malignant cells in mouse and human
EAC, in contrast to the importance of IL-11 in carcinogenesis
of the antrum (Ernst et al., 2008; Howlett et al., 2009). IL-6 in
most tissues is a critical mediator of cancer initiation and progression, and IL-6-Stat3 inhibition may be a useful target for
prevention or treatment of BE and EAC.
Unconjugated BA, which are increased in the refluxate of
patients with BE (Kauer et al., 1997) and in patients on a high
fat diet (Theisen et al., 2000), accelerated the development of
BE and dysplasia. Unconjugated BA can induce gene promoter
demethylation leading to activation of IL-6, Cdx2, or Notch1
gene expression in esophageal cells (Jankowski et al., 1999; Kazumori et al., 2006), a finding we can confirm in our BA-treated
L2-IL-1b mice. Thus, through modulation of gene expression,
unconjugated bile acids may promote an intestinal lineage
commitment by progenitors. Pathway analysis of our gene
expression studies confirm previously suggested carcinogenic
roles for BA (Bernstein et al., 2005, 1999; Dvorak et al., 2007;
Payne et al., 2005).
Although it is generally accepted that BE and EAC arise from
a common progenitor cell, the precise type and location of this
cell remained unresolved. Temporal analysis of the L2-IL-1b
mouse SCJ at different stages of the disease showed an initial
expansion of progenitors in the gastric cardia, followed by
migration over time into the esophagus (Figure 4G). LgR5 cell
lineage tracing studies demonstrated the likely origin of at least
some of the metaplastic BE tissue from Lgr5+ cells within the
gastric cardia, where Lgr5+ cells also serve as functional cardia
stem or progenitor cells. Furthermore, progenitor markers were
essentially absent from the normal esophageal squamous
epithelium, but Lgr5 (Barker et al., 2010), Tff2 (Quante et al.,
2010), Krt19 (Means et al., 2008), Cck2r (Jin et al., 2009), and
Dclk1 (Giannakis et al., 2006) were all present in the normal
mouse gastric cardia, and were significantly increased in BE.
Analysis of a cohort of human patients with BE showed

(D) Left: Lgr5-Cre-ERT x RosaLacZ mice were treated with 3-OH tamoxifen and sacrificed 1 day or 7 days postinduction. Analysis at 1 day showed a small
collection of Xgal+ cells in the cardia at the squamocolumnar junction (SCJ), whereas analysis at 7 days showed complete lineage tracing of these columnar
cardia glands. Right: lineage tracing of BE tissue in 6-month-old Lgr5-CreERT/IL-1b/RosaLacZ mice. Tamoxifen induction (6 mg in one dose) was performed prior
to bile acid treatment at the age of 4 weeks. Mice were sacrificed at 2, 4, or 6 months after induction, indicating lineage tracing of developing BE suggesting that
Lgr5 cells might migrate into the distal esophagus and give rise to BE.
(E) mRNA expression (RT-qPCR) of LGR5 and DCLK1 in biopsies of cardia tissue, obtained from five patients with BE and five patients without BE (normal).
(F) Representative DCLK1 IHC pictures of normal human cardia (left) and of cardia from patients with BE (right) with doublecortin-like kinase-1.
(G) In our model of the pathogenesis of BE and EAC in mice, bile acid treatment, and IL-1b-induced inflammation lead to migration of gastric cardia progenitor
cells into the distal esophagus, giving rise to BE and EAC in association with increased Dll1-dependent Notch signaling that induced columnar cell differentiation.
Data are represented as mean ± SEM. *p < 0.05.
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Figure 8. IL-6 Deficiency Abolishes IL1b-Induced Metaplasia and Dysplasia
(A) mRNA expression (RT-qPCR) of IL-6 in the SCJ
tissue of WT, L2-IL-1b mice, BA-treated WT, and
BA-treated L2-IL-1b mice (*p < 0.01 compared to
WT, # p < 0.05 compared to L2-IL-1b mice).
(B) Quantification of cells with phosphorylated
STAT3 in WT, L2-IL-1b mice, BA-treated L2-IL-1b,
and BA-treated L2-IL-1b mice with EAC (*p < 0.01
compared to WT, # p < 0.05 compared to L2-IL-1b
mice).
(C) Representative pictures of pSTAT3 IHC in 12month-old L2-IL-1b mice and BA-treated L2-IL-1b,
and 15-month-old BA-treated L2-IL-1b mice
with EAC.
(D and E) mRNA expression (RT-qPCR) of IL-6 (D)
and IL-1b (E) in biopsies of esophageal tissue,
obtained from 46 patients with BE.
(F) Histopathological scoring of 12-month-old
L2-IL-1b mice and L2-IL-1b/IL-6 / or L2-IL-1b/
IL-6 /+ mice and WT (C57/B6) littermates (*p <
0.05, compared to L2-IL-1b mice). Data are represented as mean ± SEM. See also Table S3.

a significant increase of identical progenitor markers in both
gastric cardia and BE tissue.
However, our findings that Lgr5+ cardia cells can contribute
to BE does not exclude contributions from other lineages. In
addition, the use of mouse models to investigate the origins of
human metaplasia has its limitations, given the anatomical
differences. The predominant theory for the origins of Barrett
esophagus is based on the notion of reflux-induced transdifferentiation of squamous epithelial cells (Barbera and Fitzgerald,
2010; Yu et al., 2005). In addition, genetic evidence has supported the possible origin from multipotent progenitors present
in submucosal squamous gland ducts, which are not present
48 Cancer Cell 21, 36–51, January 17, 2012 ª2012 Elsevier Inc.

in the mouse and thus could not be examined in our model (Jankowski et al., 2000;
Leedham et al., 2008). A recent study of
p63 null mice led to the proposal that Barrett-like metaplasia may arise from a population of Car4+/Krt7+ embryonic progenitors at the squamocolumnar junction
(Wang et al., 2011). However, each of
these alternative hypotheses, although
reasonable, is also limited to date by the
absence of dynamic lineage tracing and
the sort of mechanistic underpinnings
provided by our model.
Notch signaling appears important in
the regulation of stem cell differentiation,
and our data suggest that Dll1 is the major
ligand inducing activated Notch signaling
in BE, whereas Jagged2 may acts as an
inhibitor, similar to a model of antagonism
between different Notch ligands suggested previously (Benedito et al., 2009).
In the cardia, DII1 was expressed at the
bottom of the crypts adjacent to the location of Lgr5 cells. Notch activation in
Lgr5+ cells has been shown to correlate with lineage tracing at
the SCJ at the cardia (Kim and Shivdasani, 2011), consistent
with our hypothesis that Lgr5 cells from the gastric cardia
migrate into the distal esophagus to give rise to BE tissue with
increased Notch activation and Lgr5 expression. With the expansion of progenitor cells in BE, we observe a similar expansion of
DII1+ cells immediately adjacent to Notch expressing cells within
the metaplastic lineage. The strong correlation between DII1 with
the progenitor cell zone and proliferation, and Jagged2 with
postmitotic, differentiated cells, suggests a potential mechanism
for modulation of progenitor cell expansion and differentiation
through Notch signaling. In this model, DII1 promotes progenitor
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cell maintenance and proliferation, and Jagged2 inhibits proliferation and promotes differentiation, both a consequence of intraepithelial crosstalk between progenitor cells and their progeny.
We would further hypothesize, that the development of IM
occurs in a low Notch signaling environment, whereas maintenance of the CLE phenotype and progression to dysplasia
occurs in a high Notch signaling environment.
Taken together, our data strongly suggest that BE arises from
a gastric cardia lineage, as originally suggested (Hamilton and
Yardley, 1977). Indeed, it has been difficult to distinguish at the
histopathological level between so-called esophagogastric
‘‘junctional tumors’’ that appear localized to the cardia and
EAC, clearly present in the esophagus. The fact that BE always
begins precisely at the SCJ has never otherwise been explained,
and it now seems clear that special consideration should be
given to ‘‘carditis,’’ inflammation of the gastric cardia that may
represent a precursor lesion of BE and EAC.
EXPERIMENTAL PROCEDURES
For a detailed description of all methods see Supplemental Experimental
Procedures.
Mice
All mice studies and breeding were carried out under the approval of Institutional Animal Care and Use Committee of Columbia University. Human IL-1b
transgenic mice were generated by targeting expression of hIL-1b to
the esophagus using the Epstein-Bar virus promoter. Mice were placed on
drinking water containing bile acids (0.3% DCA, pH 7.0) at the age of 3 months.
Nine-month-old L2-IL-1b mice were subjected to a 5-day treatment regimen
with the GSI (DBZ, 30 mmol/kg). Lineage tracing studies were performed
with Lgr5-CreTM-IRES-GFP mice crossed to Rosa26R-LacZ reporter and
L2-IL-1b mice. Tamoxifen (6 mg) was given at the age of 6–8 weeks prior to
administration of BA.
Human Study
Esophageal tissue was obtained from 46 patients with BE, with and without
dysplasia. Biopsies were taken for clinical and research purposes. This study
was approved by the Columbia University Institutional Review Board and
informed consent was obtained from all patients.
ACCESSION NUMBERS
Micro array information were deposited at the Gene Expression Omnibus
database (http://www.ncbi.nlm.nih.gov/geo/) with the accession number
GSE24931.
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